SRSF2 and myeloid neoplasm: For example, microhomology-mediated recurrent deletions of CALR, ASXL1, and SRSF2 and non-recurrent deletions in TET2, DNMT3a, CEBPA, and RUNX1 have been reported in myeloid neoplasms [45].